Tatiana M Prowell

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Metastatic Breast Cancer

Drug Administration

Epidermal Growth Factor Receptor

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO clinical cancer informatics

This page only lists publications with an associated author ORCID identifier.

Publications

Jennifer K Litton, Meredith M Regan, Lajos Pusztai, Hope S Rugo, Sara M Tolaney, Elizabeth Garrett-Mayer, Laleh Amiri-Kordestani, Reva K Basho, Ana F Best, Jean-Francois Boileau, Carsten Denkert, Jared C Foster, Nadia Harbeck, Heather A Jacene, Tari A King, Ginny Mason, Ciara Catherine O'Sullivan, Tatiana M Prowell, Andrea L Richardson, Karla A Sepulveda, Mary Lou Smith, Judy A Tjoe, Gulisa Turashvili, Wendy A Woodward, Lynn Pearson Butler, Elena I Schwartz, Larissa A Korde
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Shaily Arora, Preeti Narayan, Christy L Osgood, Suparna Wedam, Tatiana M Prowell, Jennifer J Gao, Mirat Shah, Danielle Krol, Sakar Wahby, Melanie E Royce, Soma Ghosh, Reena Philip, Gwynn Ison, Tara Berman, Christina Brus, Erik W Bloomquist, Mallorie H Fiero, Shenghui Tang, Richard Pazdur, Amna Ibrahim, Laleh Amiri-Kordestani, Julia A Beaver
U.S. FDA Drug Approvals for Breast Cancer - A Decade in Review. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Jeremy Mason, Yutao Gong, Laleh Amiri-Kordestani, Suparna Wedam, Jennifer J Gao, Tatiana M Prowell, Harpreet Singh, Anup Amatya, Shenghui Tang, Richard Pazdur, Peter Kuhn, Gideon M Blumenthal, Julia A Beaver
Model Development of CDK4/6 Predicted Efficacy in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced or Metastatic Breast Cancer. JCO clinical cancer informatics 5 (2021)
Shaily Arora, Preeti Narayan, Gwynn Ison, Tara Berman, Daniel L Suzman, Suparna Wedam, Tatiana M Prowell, Soma Ghosh, Reena Philip, Christy L Osgood, Jennifer J Gao, Mirat Shah, Danielle Krol, Sakar Wahby, Melanie E Royce, Christina Brus, Erik W Bloomquist, Mallorie H Fiero, Shenghui Tang, Richard Pazdur, Amna Ibrahim, Laleh Amiri-Kordestani, Julia A Beaver
U.S. FDA Drug Approvals for Gynecological Malignancies: A Decade in Review. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Preeti Narayan, Tatiana M Prowell, Jennifer J Gao, Laura L Fernandes, Emily Li, Xiling Jiang, Junshan Qiu, Jianghong Fan, Pengfei Song, Jingyu Yu, Xinyuan Zhang, Bellinda L King-Kallimanis, Wei Chen, Tiffany K Ricks, Yutao Gong, Xing Wang, Katherine Windsor, Steve Y Rhieu, Gerlie Geiser, Anamitro Banerjee, Xiaohong Chen, Francisca Reyes Turcu, Deb K Chatterjee, Anand Pathak, Jeffrey Seidman, Soma Ghosh, Reena Philip, Kirsten B Goldberg, Paul G Kluetz, Shenghui Tang, Laleh Amiri-Kordestani, Marc R Theoret, Richard Pazdur, Julia A Beaver
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (7) (2020)